Catalyst Pharmaceuticals (CPRX) Depreciation & Amortization (CF) (2010 - 2026)
Catalyst Pharmaceuticals posted quarterly Depreciation & Amortization (CF) of $70000.0 for Q1 2026, down 39.13% year-on-year from $115000.0 in Q1 2025, and down 2.78% on a QoQ basis from $72000.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $70000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 39.13% year-over-year to $70000.0; the trailing twelve-month figure through Mar 2026 stood at $330000.0 (down 22.54% YoY), and the FY2025 full-year result was $375000.0, down 5.54% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $70000.0, down from $72000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $116000.0 in Q2 2025 and bottomed at $34000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $81000.0 (2023), against an average of $76411.8.
- The widest annual swing landed in 2022, when Depreciation & Amortization (CF) plunged 64.95%; it then jumped 140.0% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $35000.0 in 2022, then surged by 140.0% to $84000.0 in 2023, then surged by 35.71% to $114000.0 in 2024, then plunged by 36.84% to $72000.0 in 2025, then declined by 2.78% to $70000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $70000.0 (Q1 2026), $72000.0 (Q4 2025), and $72000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70,000.00 |
| Mar 31, 2026 | 70,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Sep 30, 2025 | 72,000.00 |
| Sep 30, 2025 | 72,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Jun 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 91,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Sep 30, 2023 | 81,000.00 |
| Sep 30, 2023 | 81,000.00 |
| Jun 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 82,000.00 |
| Mar 31, 2023 | 69,000.00 |
| Mar 31, 2023 | 69,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 35,000.00 |
| Sep 30, 2022 | 35,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Mar 31, 2022 | 34,000.00 |
| Mar 31, 2022 | 34,000.00 |
| Dec 31, 2021 | 33,000.00 |
| Dec 31, 2021 | 33,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Jun 30, 2021 | 31,000.00 |
| Jun 30, 2021 | 31,000.00 |
| Mar 31, 2021 | 97,000.00 |
| Mar 31, 2021 | 97,000.00 |
| Dec 31, 2020 | 19,000.00 |
| Dec 31, 2020 | 19,000.00 |
| Sep 30, 2020 | 30,000.00 |
| Sep 30, 2020 | 30,000.00 |
| Jun 30, 2020 | 29,000.00 |
| Jun 30, 2020 | 29,000.00 |
| Mar 31, 2020 | 14,000.00 |
| Mar 31, 2020 | 14,000.00 |
| Dec 31, 2019 | 28,282.00 |
| Dec 31, 2019 | 28,282.00 |
| Sep 30, 2019 | 6,532.00 |
| Sep 30, 2019 | 6,532.00 |
| Jun 30, 2019 | 6,438.00 |
| Jun 30, 2019 | 6,438.00 |
| Mar 31, 2019 | 13,748.00 |
| Mar 31, 2019 | 13,748.00 |
| Dec 31, 2018 | 12,493.00 |
| Dec 31, 2018 | 12,493.00 |
| Sep 30, 2018 | 9,294.00 |
| Sep 30, 2018 | 9,294.00 |
| Jun 30, 2018 | 8,176.00 |
| Jun 30, 2018 | 8,176.00 |
| Mar 31, 2018 | 8,015.00 |
| Mar 31, 2018 | 8,015.00 |
| Dec 31, 2017 | 6,935.00 |
| Dec 31, 2017 | 6,935.00 |
| Sep 30, 2017 | 12,839.00 |
| Sep 30, 2017 | 12,839.00 |
| Jun 30, 2017 | 12,957.00 |
| Jun 30, 2017 | 12,957.00 |
| Mar 31, 2017 | 12,958.00 |
| Mar 31, 2017 | 12,958.00 |
| Dec 31, 2016 | 11,964.00 |
| Dec 31, 2016 | 11,964.00 |
| Sep 30, 2016 | 9,482.00 |
| Sep 30, 2016 | 9,482.00 |
| Jun 30, 2016 | 8,762.00 |
| Jun 30, 2016 | 8,762.00 |
| Mar 31, 2016 | 13,198.00 |
| Mar 31, 2016 | 13,198.00 |
| Dec 31, 2015 | 6,086.00 |
| Dec 31, 2015 | 6,086.00 |
| Sep 30, 2015 | 11,259.00 |
| Sep 30, 2015 | 11,259.00 |
| Jun 30, 2015 | 8,975.00 |
| Jun 30, 2015 | 8,975.00 |
| Mar 31, 2015 | 8,148.00 |
| Mar 31, 2015 | 8,148.00 |
| Dec 31, 2014 | 7,971.00 |
| Dec 31, 2014 | 7,971.00 |
| Sep 30, 2014 | 7,235.00 |
| Sep 30, 2014 | 7,235.00 |
| Jun 30, 2014 | 6,083.00 |
| Jun 30, 2014 | 6,083.00 |
| Mar 31, 2014 | 5,285.00 |
| Mar 31, 2014 | 5,285.00 |
| Dec 31, 2013 | 5,706.00 |
| Dec 31, 2013 | 5,706.00 |
| Sep 30, 2013 | 5,707.00 |
| Sep 30, 2013 | 5,707.00 |
| Jun 30, 2013 | 5,706.00 |
| Jun 30, 2013 | 5,706.00 |
| Mar 31, 2013 | 5,364.00 |
| Mar 31, 2013 | 5,364.00 |
| Dec 31, 2012 | 2,653.00 |
| Dec 31, 2012 | 2,653.00 |
| Sep 30, 2012 | 2,725.00 |
| Sep 30, 2012 | 2,725.00 |
| Jun 30, 2012 | 2,710.00 |
| Jun 30, 2012 | 2,710.00 |
| Mar 31, 2012 | 2,801.00 |
| Mar 31, 2012 | 2,801.00 |
| Dec 31, 2011 | 7,915.00 |
| Dec 31, 2011 | 7,915.00 |
| Sep 30, 2011 | 7,452.00 |
| Sep 30, 2011 | 7,452.00 |
| Mar 31, 2011 | 6,438.00 |
| Mar 31, 2011 | 6,438.00 |
| Dec 31, 2010 | 6,427.00 |
| Dec 31, 2010 | 6,427.00 |
| Sep 30, 2010 | 6,234.00 |
| Sep 30, 2010 | 6,234.00 |